Effects of dapagliflozin on new-onset diabetes in patients with heart failure: a pooled, participant-level analysis of the DAPA-HF and DELIVER trials
11 May 2024 (08:00 - 20:00)
Organised by: 
About the speaker
Herlev and Gentofte Hospital, Copenhagen (Denmark)
3 More presentations in this session
Doctor F. Schlotter (Mainz, DE)
Ms G. Sun (Guangzhou, CN)
Access the full session
The Event
Heart Failure 2024
11 May - 14 May 2024
